跳至主要内容
临床试验/NCT06474325
NCT06474325尚未招募不适用

Feasibility and Acceptability of Mobile Mental Health Application for the Improvement of Medication Adherence in Persons With Schizophrenia(SZ) and Schizoaffective Disorder(SZA)

University of Pittsburgh1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2027年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
44
试验地点
1
主要终点
Feasibility of Mobile app

研究概览

简要总结

A new mental health application will be developed for persons with schizophrenia and schizoaffective disorder. The aim is to look at whether it is feasible to use a mobile health application for improving medication adherence in persons with schizophrenia and schizoaffective disorder and whether it is acceptable to that population.

详细描述

Many interventions have been tried to improve the medication adherence of patients with schizophrenia. Individualized interventions using like setting alarms and using checklists have shown significant improvement in compliance with the medications. In the era of mobile applications most of the persons use mobile applications for multiple purposes, which have the potential to influence the life of a person in many ways. A meta-analysis conducted in 2016 showed that 66.4% of psychotic patients owned a mobile phone. A study conducted in North India found that 84.4% of patients with severe mental disorders owned a mobile phone. So if used properly it can also help in improving the life of a person with SZ.

Many mobile applications have been used to improve medication compliance in general. But only a few mobile applications have specifically focused the persons with schizophrenia. Very few studies have investigated the efficacy of mobile applications to improve medication adherence in patients with schizophrenia. This study will be assessing the feasibility of developing a mobile application and using the application for improving compliance of medications in persons with schizophrenia and schizoaffective disorder.

Primary aims:

  • To develop a mobile mental health application for the improvement of medication adherence in persons with schizophrenia and schizoaffective disorder
  • To assess the feasibility and the acceptability of using a mobile mental health application for improving the medication adherence of persons with schizophrenia and schizoaffective disorder

Primary Objectives:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Persons diagnosed with schizophrenia and schizoaffective disorder and are in remission for past two months.
  • Age 18-60 years of any gender.
  • Able to read and understand Malayalam/ English

排除标准

  • Patients who have active psychotic or mood symptoms.
  • History of substance use (except nicotine)
  • Having any serious physical illness. -

研究组 & 干预措施

Intervention via mobile app

Experimental

Intervention via mobile application include psychoeducational videos, reminders, and virtual rewards and badges for completing the challenges to encourage adherence of medications

干预措施: Intervention via mobile application (Behavioral)

结局指标

主要结局

Feasibility of Mobile app

时间窗: Baseline and after three months

To assess the feasibility and the acceptability with a mobile mental health application for medication adherence in persons with SZ and schizoaffective disorder using Acceptability Questionnaire. The scale ranges from 0 to 50.

Acceptibility of Mobile app

时间窗: Baseline and after three months

To assess the feasibility and the acceptability with a mobile mental health application for medication adherence in persons with SZ and schizoaffective disorder using Perception of treatment Acceptability scale (Score (0-5) 0= Not at all 5 =very much). Ranges from 0 to 50. )

Adherence to medication

时间窗: Baseline and after three months

To compare the Medication adherence rating scale scores before and after using mental health application for changing medication adherence in persons with schizophrenia and schizoaffective disorder

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vishwajit Nimgaonkar, MD PhD

Professor

University of Pittsburgh

研究点 (1)

Loading locations...

相似试验